Regulus Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.98B 262.7M 2025-03
Celldex Therapeutics USD 702.98M 44.02M 2025-03
Cipla INR 311.93B 27.38B 2025-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 54.91M 5.57M 2024-12
CSL USD 20.55B 3.18B 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Grifols EUR 5.88B 533.83M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
Merck USD 48.34B 2.02B 2025-03
Sanofi 77.86B 4.86B 2024-12
Takeda JPY 6.94T 483.19B 2025-03



Regulus Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.